Investigational Site Number : 100001

Sofia 1680

3 studies enrolling now · 8 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Cerebroside Lipidosis Syndrome, Diabetes Mellitus, Type 2, Fabry Disease, Gaucher Disease, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease, Glycogen Storage Disease Type II, Hypercholesterolemia, Multiple Sclerosis, Pompe Disease, Sphingomyelin Lipidosis

Studies at this site

• Pompe Disease Registry Protocol — Recruiting now
• Fabry Disease Registry & Pregnancy Sub-registry — Recruiting now
• International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry — Recruiting now
• Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis — Completed
• Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency — Completed
• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab — Completed
• Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist — Completed
• Long-term Safety and Tolerability of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY Long Term) — Completed